Johnson & Johnson (NYSE:JNJ) is among the best dividend stocks for a bear market. The company is facing a combination of slow ...

With a backdrop of mounting industry disruption and transition, Pharm Exec’s latest listing of the top global biopharma sales ...

During a live event, Neal E. Ready, MD, and participants discussed use of PD-L1 status in non–small cell lung cancer and ...

Many established medical therapies to treat myasthenia gravis remain in use, and newer options are available for patients who ...

It is hard to think of a less coherent pair of policies: President Trump’s tax policy encourages the very offshoring that his ...

Johnson & Johnson (JNJ) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to ...

This isn't Johnson's first attempt to purchase an English soccer club. The former United Kingdom Ambassador made an approach ...

You should consider the Invesco Pharmaceuticals ETF (PJP), a passively managed exchange traded fund launched on 06/23/2005. Passively managed ETFs are becoming increasingly popular with institutional ...

Johnson & Johnson is an impeccable dividend stock with a streak of 63 consecutive dividend raises. The company's long history ...

For decades, pharmaceutical companies have shelled out big bucks to broadcasters to place ads between TV segments. But a pair of policies being considered by US Health and Human Services Secretary ...

Johnson City will celebateOrganizers expressed excitement about this year's lineup, which includes the return of Noah Spencer ...

During the Covid-19 pandemic, South African and Colombian civil society organisations initiated strategic litigation against their governments to gain transparency on confidential vaccine contracts ...